These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32167395)

  • 41. Identification of discrepancies between adverse drug reactions coded by medical records technicians and those reported by the pharmacovigilance team in pediatrics: An intervention to improve identification, reporting, and coding.
    Soyer J; Necsoiu D; Desjardins I; Lebel D; Bussières JF
    Arch Pediatr; 2019 Oct; 26(7):400-406. PubMed ID: 31611146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantification of Adverse Drug Reactions Related to Drug Switches in The Netherlands.
    Glerum PJ; Maliepaard M; de Valk V; Scholl JHG; van Hunsel FPAM; van Puijenbroek EP; Burger DM; Neef K
    Clin Transl Sci; 2020 May; 13(3):599-607. PubMed ID: 32052597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study of analysis 1 390 adverse drug reactions cases of parenterally administered dengzhan xixin based on China's spontaneous response system].
    Li YY; Xiang YY; Xie YM; Shen H
    Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(18):2998-3002. PubMed ID: 24471319
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacovigilance in children in Camagüey Province, Cuba.
    Bárzaga Arencibia Z; López Leyva A; Mejías Peña Y; González Reyes AR; Fernández Manzano E; Choonara I
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1079-84. PubMed ID: 22315149
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Adverse drug reactions in pediatrics: Experience of a regional pharmacovigilance center].
    Saint-Martin C; Kanagaratnam L; de Boissieu P; Azzouz B; Abou Taam M; Trenque T
    Therapie; 2016 Oct; 71(5):467-473. PubMed ID: 27203165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suspected adverse drug reaction reports with oral anticoagulants in Portugal: a pharmacovigilance study.
    Caldeira D; Rodrigues R; Abreu D; Anes AM; Rosa MM; Ferreira JJ
    Expert Opin Drug Saf; 2018 Apr; 17(4):339-345. PubMed ID: 29463153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Adverse drug reactions in adolescents: a review of reporting to a national pharmacovigilance system.
    Rebelo Gomes E; Ribeiro-Vaz I; Santos CC; Herdeiro MT
    Expert Opin Drug Saf; 2020 Jul; 19(7):915-922. PubMed ID: 32422079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.
    Pugi A; Bonaiuti R; Maggini V; Moschini M; Tuccori M; Leone R; Rossi M; Motola D; Piccinni C; Ferrazin F; Sottosanti L; Mugelli A; Vannacci A; Lapi F
    Am J Health Syst Pharm; 2013 Jun; 70(12):1039-46. PubMed ID: 23719881
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patients' contribution to drug safety in Catalonia: the interest of personal feelings on adverse drug reactions.
    Riera-Arnau J; Alvarado Aguirre LA; Garcia Doladé N; Vidal Guitart X; Figueras A; Cereza García G
    Eur J Clin Pharmacol; 2021 Apr; 77(4):637-642. PubMed ID: 33170306
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database.
    Cazacu I; Stroe R; Dondera R; Mogosan C; Haramburu F; Fourrier-Réglat A; Loghin F
    Fundam Clin Pharmacol; 2018 Jun; 32(3):330-336. PubMed ID: 29314262
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adverse drug reactions in infants, children and adolescents exposed to antidepressants: a French pharmacovigilance study.
    Barthez S; Revet A; Chouchana L; Jonville-Bera AP; Pizzoglio V; Raynaud JP; Chebane L; Lapeyre-Mestre M; Montastruc F
    Eur J Clin Pharmacol; 2020 Nov; 76(11):1591-1599. PubMed ID: 32588107
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bevacizumab-induced serious side-effects: a review of the French pharmacovigilance database.
    Taugourdeau-Raymond S; Rouby F; Default A; Jean-Pastor MJ;
    Eur J Clin Pharmacol; 2012 Jul; 68(7):1103-7. PubMed ID: 22349162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hospital registration of adverse drug reactions in electronic health records: importance and contribution to pharmacovigilance.
    Alloush R; van Lint J; van Marum RJ; Hermens WWAJJ; Jessurun NT
    Expert Opin Drug Saf; 2024 Jul; 23(7):925-935. PubMed ID: 37961907
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patterns of adverse drug reactions in Jordan: a retrospective analysis of the National Pharmacovigilance Data Registry (2015-2021).
    Mhaidat NM; Alshogran OY; Altawalbeh SM; Jaber JM; Banat HA; Ahmad DS; Alabsi W
    Expert Opin Drug Saf; 2023; 22(10):957-965. PubMed ID: 37293991
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adverse drug reactions in children: a ten-year review of reporting to the Portuguese Pharmacovigilance System.
    Nogueira Guerra L; Herdeiro MT; Ribeiro-Vaz I; Clérigo MI; Rocha C; Araújo A; Pêgo A; Rebelo Gomes E
    Expert Opin Drug Saf; 2015; 14(12):1805-13. PubMed ID: 26549822
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical characteristics of adverse events associated with therapeutic monoclonal antibodies in Korea.
    Sim DW; Park KH; Park HJ; Son YW; Lee SC; Park JW; Lee JH
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1279-1286. PubMed ID: 27364925
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Knowledge, awareness, perception and reporting of experienced adverse drug reactions among outpatients in Nigeria.
    Adisa R; Adeniyi OR; Fakeye TO
    Int J Clin Pharm; 2019 Aug; 41(4):1062-1073. PubMed ID: 31140162
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Drug induced hepatotoxicity: data from the Serbian pharmacovigilance database.
    Petronijevic M; Ilic K; Suzuki A
    Pharmacoepidemiol Drug Saf; 2011 Apr; 20(4):416-23. PubMed ID: 21370308
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quality of Spontaneous Reports of Adverse Drug Reactions Sent to a Regional Pharmacovigilance Unit.
    Salvador MR; Monteiro C; Pereira L; Duarte AP
    Int J Environ Res Public Health; 2022 Mar; 19(7):. PubMed ID: 35409436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.